Blood cancers, Myeloma
Results
Phase 2
This trial looked at a combination of bortezomib, adriamycin and dexamethasone (PAD) for myeloma. It was for people who had not had any other treatment for their myeloma.
The trial was open for people to join between 2011 and 2014. The team published the results in 2021.
Recruitment start: 1 March 2011
Recruitment end: 31 January 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Kwee L Yong
Blood Cancer UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University College London (UCL)
Janssen Cilag
Chugai Pharma UK
Last reviewed: 9 May 2022
CRUK internal database number: 7445
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
